IL-17A+ IFN-γ+ double-positive CD4+ T cells were detected in the inflamed mucosa of IBD patients, contributing to elevated IFN-γ and IL-17A levels in the gut compared to healthy individuals [21]. This evidence concerns the gene IL17A and inflammatory bowel disease.